Adults 18 to younger than 65 years of age living with overweight or obesity may qualify for a clinical research study evaluating an investigational once-weekly GLP-1/GIP injection for weight management.
Obesity or Overweight Study
Age Range:
18 to 65
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This clinical research study is evaluating an investigational once-weekly GLP-1/GIP injection in adults with overweight or obesity who do not have diabetes. Researchers are studying whether this investigational medication may help support weight management while evaluating its safety and effectiveness. Participants will receive either the investigational study medication or placebo, and all participants will receive guidance on healthy nutrition and physical activity throughout the study.
Qualifications
You may be able to join if you:
- Are older than 18 years of age and younger than 65 years of age.
- Have a Body Mass Index (BMI) of 30 to less than 45, or a BMI of 27 to less than 30 with at least one weight-related medical condition.
- Do not have a diagnosis of type 1 or type 2 diabetes.
- Are willing to receive a once-weekly study injection and attend all scheduled study visits.
- Are willing to complete study procedures, including fasting laboratory visits, electronic diary entries, and 24-hour blood pressure monitoring.
*Other qualifications may be determined by the study team.
FEATURED STUDIES
Adults with osteoarthritis (OA) knee pain may qualify for a research study evaluating an investigational medication for chronic pain relief.
Adults 18 to 75 years of age may qualify for a research study evaluating an investigational medication for migraine attacks.
Adults ages 18 to 70 who experience episodic migraine may qualify for a clinical research study evaluating an investigational medication […]
Adults 18 to younger than 65 years of age living with overweight or obesity may qualify for a clinical research […]
A vaccine research study is expected to open for enrollment in the coming weeks. Join our notification list to be […]
Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), […]